Two Sigma Investments, LP Tenaya Therapeutics, Inc. Transaction History
Two Sigma Investments, LP
- $41.6 Billion
- Q4 2024
A detailed history of Two Sigma Investments, LP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 44,771 shares of TNYA stock, worth $53,725. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,771
Previous 54,714
18.17%
Holding current value
$53,725
Previous $105,000
39.05%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TNYA
# of Institutions
86Shares Held
43.7MCall Options Held
74.3KPut Options Held
192K-
Column Group LLC San Francisco, CA9.4MShares$11.3 Million24.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$8.08 Million0.83% of portfolio
-
Jpmorgan Chase & CO New York, NY5.16MShares$6.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$4.89 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$3.93 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $49.6M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...